Stifel cuts CRISPR Therapeutics target to $49, holds rating
Stifel analysts adjusted their outlook on CRISPR Therapeutics (NASDAQ:CRSP), currently trading at $43.09 with a market capitalization of $3.7 billion, reducing the price target to $49 from the ...
Stifel raises HubSpot stock price target to $925, maintains buy rating
Stifel analysts updated their outlook on HubSpot Inc (NYSE: NYSE:HUBS), raising the stock's price target from the previous $880.00 to a new figure of $925.00. The firm continues to endorse the stock ...
Stifel Raises Energy Transfer LP (ET) Price Target to $23, Citing Growth Plans and Data Center Deal
We recently compiled a list of the 10 AI News and Ratings Making Waves on Wall Street. In this article, we are going to take ...
Stifel Nicolaus Keeps Their Hold Rating on Rapid7 (RPD)
Stifel Nicolaus analyst Adam Borg maintained a Hold rating on Rapid7 (RPD – Research Report) today and set a price target of $38.00. The ...
Stifel Nicolaus Sticks to Its Buy Rating for Casella Waste (CWST)
In a report released today, Brian Butler from Stifel Nicolaus maintained a Buy rating on Casella Waste (CWST – Research Report), with a price ...
U.S. investors, Big Pharma race to find new medicines in China
U.S. investors and large pharmaceutical companies are increasingly doing deals in China as the country’s biopharma sector ...
Stifel Nicolaus Issues Pessimistic Forecast for Onsemi (NASDAQ:ON) Stock Price
Onsemi (NASDAQ:ON – Get Free Report) had its price objective reduced by research analysts at Stifel Nicolaus from $60.00 to $52.00 in a research note issued on Tuesday,Benzinga reports. The firm ...
Stifel Nicolaus Lowers SPS Commerce (NASDAQ:SPSC) Price Target to $200.00
SPS Commerce (NASDAQ:SPSC – Get Free Report) had its price target decreased by analysts at Stifel Nicolaus from $225.00 to $200.00 in a report released on Tuesday,Benzinga reports. The brokerage ...